Monocytes, particularly nonclassical ones, lose their opsonic and nonopsonic phagocytosis capacity during pediatric cerebral malaria.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 20 12 2023
accepted: 17 04 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

Innate immunity is crucial to reducing parasite burden and contributing to survival in severe malaria. Monocytes are key actors in the innate response and, like macrophages, are plastic cells whose function and phenotype are regulated by the signals from the microenvironment. In the context of cerebral malaria (CM), monocyte response constitutes an important issue to understand. We previously demonstrated that decreased percentages of nonclassical monocytes were associated with death outcomes in CM children. In the current study, we postulated that monocyte phagocytosis function is impacted by the severity of malaria infection. To study this hypothesis, we compared the opsonic and nonopsonic phagocytosis capacity of circulant monocytes from Beninese children with uncomplicated malaria (UM) and CM. For the CM group, samples were obtained at inclusion (D0) and 3 and 30 days after treatment (D3, D30). The phagocytosis capacity of monocytes and their subsets was characterized by flow cytometry and transcriptional profiling by studying genes known for their functional implication in infected-red blood cell (iRBC) elimination or immune escape. Our results confirm our hypothesis and highlight the higher capacity of nonclassical monocytes to phagocyte iRBC. We also confirm that a low number of nonclassical monocytes is associated with CM outcome when compared to UM, suggesting a mobilization of this subpopulation to the cerebral inflammatory site. Finally, our results suggest the implication of the inhibitory receptors LILRB1, LILRB2, and Tim3 in phagocytosis control. Taken together, these data provide a better understanding of the interplay between monocytes and malaria infection in the pathogenicity of CM.

Identifiants

pubmed: 38835780
doi: 10.3389/fimmu.2024.1358853
pmc: PMC11148436
doi:

Substances chimiques

Opsonin Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1358853

Informations de copyright

Copyright © 2024 Vianou, Royo, Dechavanne, Bertin, Yessoufou, Houze, Faucher and Aubouy.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Bertin Vianou (B)

UMR152 PHARMADEV, IRD, UPS, Toulouse University, Toulouse, France.
Clinical Research Institute of Benin (IRCB), Abomey Calavi, Benin.

Jade Royo (J)

UMR152 PHARMADEV, IRD, UPS, Toulouse University, Toulouse, France.

Sébastien Dechavanne (S)

UMR261 Mère et Enfant en Milieu tropical (MERIT), Université Paris Cité, IRD, Paris, France.

Gwladys I Bertin (GI)

UMR261 Mère et Enfant en Milieu tropical (MERIT), Université Paris Cité, IRD, Paris, France.

Akadiri Yessoufou (A)

Cell Biology and Physiology Laboratory, Abomey Calavi University (UAC), Abomey Calavi, Benin.

Sandrine Houze (S)

UMR261 Mère et Enfant en Milieu tropical (MERIT), Université Paris Cité, IRD, Paris, France.
French Malaria Reference Center, Assistance Publique - Hôpitaux de Paris (APHP), Bichat Hospital, Paris, France.
Parasitology Laboratory, Assistance Publique - Hôpitaux de Paris (APHP), Bichat-Claude-Bernard Hospital, Paris, France.

Jean-François Faucher (JF)

Infectious Diseases and Tropical Medicine Department, Limoges University Hospital, Limoges, France.
Unité Mixte de Recherche (UMR) 1094 EpiMaCT, Inserm, Limoges University Hospital, Limoges University, Limoges, France.

Agnes Aubouy (A)

UMR152 PHARMADEV, IRD, UPS, Toulouse University, Toulouse, France.
Clinical Research Institute of Benin (IRCB), Abomey Calavi, Benin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH